methylprednisolone has been researched along with Catatonia in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Bey, AL; Frankovich, J; Gallentine, W; Gorman, MP; Jiang, YH; Kohlenberg, TM; Van Haren, K | 1 |
Chatterjee, SS; Ghosal, MK; Mitra, S | 1 |
Bachmann, S; Schröder, J | 1 |
Abe, K; Hamakawa, Y; Manabe, Y; Omori, N; Ono, Y | 1 |
1 review(s) available for methylprednisolone and Catatonia
Article | Year |
---|---|
Subacute Neuropsychiatric Syndrome in Girls With
Topics: Adolescent; Aggression; Antipsychotic Agents; Anxiety; Autism Spectrum Disorder; Catatonia; Child; Compulsive Behavior; Crying; Developmental Disabilities; Female; Frameshift Mutation; Hallucinations; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Immunotherapy; Irritable Mood; Methylprednisolone; Mutism; Nerve Tissue Proteins; Neuroprotective Agents; Obsessive-Compulsive Disorder; Recurrence; Self Care; Sleep Initiation and Maintenance Disorders; Stereotyped Behavior; Syndrome; Urinary Incontinence; Urinary Retention | 2020 |
3 other study(ies) available for methylprednisolone and Catatonia
Article | Year |
---|---|
Psychosis and catatonia as presenting features of anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antipsychotic Agents; Catatonia; Diagnosis, Differential; Female; Humans; Methylprednisolone; Olanzapine; Plasmapheresis; Psychotic Disorders | 2017 |
Catatonic syndrome related to acute disseminated encephalomyelitis (ADEM).
Topics: Adult; Anti-Inflammatory Agents; Antipsychotic Agents; Brain; Catatonia; Clozapine; Encephalomyelitis, Acute Disseminated; Female; Humans; Magnetic Resonance Imaging; Methylprednisolone; Oligoclonal Bands; Temporal Lobe | 2006 |
Steroid-responsive encephalitis lethargica syndrome with malignant catatonia.
Topics: Catatonia; Electroencephalography; Glucocorticoids; Humans; Infusions, Intravenous; Male; Methylprednisolone; Middle Aged; Parkinson Disease, Postencephalitic; Treatment Outcome | 2007 |